Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Legionnaires' dise4ase: macrolides or quinolones? (CROSBI ID 560670)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa

Kuzman, Ilija ; Puljiz, Ivan ; Skuhala, Tomislava Legionnaires' dise4ase: macrolides or quinolones? // 6th Croatian Congress on Infectious Diseases (abstract Book). 2009. str. 29-30

Podaci o odgovornosti

Kuzman, Ilija ; Puljiz, Ivan ; Skuhala, Tomislava

engleski

Legionnaires' dise4ase: macrolides or quinolones?

Our clinical experience shows that early antibiotic treatment with newer macrolides (azithromycin) and fluoroquinolones (moxifloxacin) was clinically very effective and essential for outcome of illness. The results suggest that moxifloxacin may have a superior clinical response compared to azithromycin with regards to defervescence,

Legionnaires' disease; macrolides; fluoroquinolones

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

29-30.

2009.

objavljeno

Podaci o matičnoj publikaciji

6th Croatian Congress on Infectious Diseases (abstract Book)

Podaci o skupu

6th Croatian Congress on Infectious Diseases

pozvano predavanje

24.10.2009-27.10.2009

Šibenik, Hrvatska

Povezanost rada

Kliničke medicinske znanosti